ABEO
ABEO
NASDAQ · Biotechnology

Abeona Therapeutics Inc

$4.29
-0.04 (-0.92%)
As of Mar 29, 10:31 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +228.4% upside
Low Target $7.81
Average Target $14.09
High Target $15.42
Current Price $4.29
Current
$4.29
Target
$14.09
$7.81 $14.09 avg $15.42
Scenario Analysis
Bear Case
$7.81
82.1%
Low target
Base Case
$14.09
+228.4%
Avg target
Bull Case
$15.42
+259.4%
High target
Risk/Reward
3.2x
Highly favorable
Price in Context
52-Week High
$7.54
-43.1% from high
52-Week Low
$3.93
+9.1% from low
Target vs 52W High
$14.09
+86.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%